Výsledky vyhledávání

Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep . 2021;6:613-623.

Autor: Provenzano R; School of Medicine, Wayne State University, Detroit, Michigan, USA., Fishbane S; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA., Szczech L; FibroGen, Inc., San Francisco, California, USA., Leong R; FibroGen, Inc., San Francisco, California, USA., Saikali KG; FibroGen, Inc., San Francisco, California, USA., Zhong M; FibroGen, Inc., San Francisco, California, USA., Lee TT; FibroGen, Inc., San Francisco, California, USA., Houser MT; AstraZeneca, Gaithersburg, Maryland, USA., Frison L; AstraZeneca, Mölndal, Sweden., Houghton J; AstraZeneca, Gaithersburg, Maryland, USA., Little DJ; AstraZeneca, Gaithersburg, Maryland, USA., Peony Yu KH; FibroGen, Inc., San Francisco, California, USA., Neff TB; FibroGen, Inc., San Francisco, California, USA.

Publikováno v: Kidney international reports [Kidney Int Rep] 2022 Feb 05; Vol. 7 (3), pp. 665. Date of Electronic Publication: 2022 Feb 05 (Print Publication: 2022).

Zobrazit plný text záznamu

Akademický článek

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.

Publikováno v: Kidney international reports [Kidney Int Rep] 2020 Dec 24; Vol. 6 (3), pp. 613-623. Date of Electronic Publication: 2020 Dec 24 (Print Publication: 2021).

Zobrazit plný text záznamu

Akademický článek

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.

Autor: Richeldi L; Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: luca.richeldi@policlinicogemelli.it., Fernández Pérez ER; National Jewish Health, Denver, CO, USA., Costabel U; Ruhrlandklinik, University Hospital, Essen, Germany., Albera C; University of Torino, Italy., Lederer DJ; Columbia University Medical Center, New York, NY, USA., Flaherty KR; University of Michigan, Ann Arbor, MI, USA., Ettinger N; St Luke's Hospital, Chesterfield, MO, USA., Perez R; University of Louisville, Louisville, KY, USA., Scholand MB; University of Utah, Lung Health Research, Salt Lake City, UT, USA., Goldin J; MedQIA, Los Angeles, CA, USA., Peony Yu KH; FibroGen, San Francisco, CA, USA., Neff T; FibroGen, San Francisco, CA, USA., Porter S; FibroGen, San Francisco, CA, USA., Zhong M; FibroGen, San Francisco, CA, USA., Gorina E; FibroGen, San Francisco, CA, USA., Kouchakji E; FibroGen, San Francisco, CA, USA., Raghu G; University of Washington Medical Center, Seattle, WA, USA.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2020 Jan; Vol. 8 (1), pp. 25-33. Date of Electronic Publication: 2019 Sep 28.

Zobrazit plný text záznamu

Akademický článek

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.

Autor: Chen N; Institute of Nephrology, Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Qian J; Renji Hospital, Shanghai, China., Chen J; Zhejiang University, Hangzhou, China., Yu X; Sun Yat-Sen University, Guangzhou, China., Mei C; Changzheng Hospital, Shanghai, China., Hao C; Shanghai Huashan Hospital, Shanghai, China., Jiang G; Xinhua Hospital, Jiaotong University, Shanghai, China., Lin H; Dalian Medical University, Dalian, China., Zhang X; Shenzhen People's Hospital, Shenzhen, China., Zuo L; Beijing University First Hospital, Beijing, China., He Q; Sichuan Province Hospital, Chengdu, China., Fu P; West China Hospital, Chengdu, China., Li X; Union Medical College Hospital, Beijing, China., Ni D; FibroGen, Inc., San Francisco, CA, USA., Hemmerich S; FibroGen, Inc., San Francisco, CA, USA., Liu C; FibroGen, Inc., San Francisco, CA, USA., Szczech L; FibroGen, Inc., San Francisco, CA, USA., Besarab A; FibroGen, Inc., San Francisco, CA, USA., Neff TB; FibroGen, Inc., San Francisco, CA, USA., Peony Yu KH; FibroGen, Inc., San Francisco, CA, USA., Valone FH; FibroGen, Inc., San Francisco, CA, USA.

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2017 Aug 01; Vol. 32 (8), pp. 1373-1386.

Zobrazit plný text záznamu